COVID-19 Treatment Success After Repeat Courses of Azithromycin: A Report of Three Cases

Infect Disord Drug Targets. 2021;21(6):e170721188439. doi: 10.2174/1871526520999201126203510.

Abstract

Background: Azithromycin has been considered as a possible therapeutic agent for COVID-19 patients. However, there is limited data on its efficacy.

Case presentation: We describe three patients diagnosed with COVID-19 who did not respond to the initial treatment but improved dramatically upon adding azithromycin with a successful outcome.

Conclusion: We have presented evidence of the potential beneficial effect of the azithromycin in the treatment of patients with COVID-19 in three different clinical settings. More evidence is needed regarding the microbiological data, safety, and efficacy of this medication in the management of COVID-19.

Keywords: Coronavirus disease 2019 (COVID-19); Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); atazanavir; azithromycin; hydroxychloroquine; ritonavir..

Publication types

  • Case Reports

MeSH terms

  • Azithromycin* / therapeutic use
  • COVID-19 Drug Treatment*
  • Humans
  • Hydroxychloroquine
  • SARS-CoV-2

Substances

  • Hydroxychloroquine
  • Azithromycin